Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-04-14 | 2023-10-20 | 189656 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154753 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2024-04-12 | 2024-06-14 | 225020 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2021-08-16 | 2021-10-12 | 144201 |
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2023-07-07 | 2024-01-12 | 197876 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-11-10 | 2024-01-12 | 209930 |
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2025-03-07 | 2025-03-28 | 252145 |
| APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-12-04 | 2020-12-11 | 129598 |
| APO-CETIRIZINE | 5MG | TABLET | Resolved | 2017-08-13 | 2018-05-31 | 19090 |
| APO-CETIRIZINE | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155311 |
| APO-CETIRIZINE | 20MG | TABLET | Resolved | 2021-10-29 | 2021-12-06 | 148496 |
| APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-07-08 | 2020-09-01 | 119696 |
| APO-CHLORTHALIDONE | 50MG | TABLET | Actual shortage | 2024-12-19 | 2025-03-07 | 246071 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-03-20 | 2019-01-03 | 3520 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-04-11 | 2018-12-20 | 6414 |
| APO-CICLOPIROX | 8% | SOLUTION | Resolved | 2018-11-14 | 2019-05-24 | 66919 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2018-03-13 | 2018-05-23 | 42675 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2018-04-02 | 2018-05-09 | 44492 |
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107693 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107711 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |